Sol-Gel Technologies (SLGL) Shares Outstanding (Weighted Average) (2016 - 2026)

Sol-Gel Technologies (SLGL) reported Shares Outstanding (Weighted Average) of $2.8 million for Q1 2026, up 1.84% year-over-year from $2.8 million in Q1 2025, and up 1.83% quarter-over-quarter from $2.8 million in Q4 2025.

Sol-Gel Technologies (SLGL) Shares Outstanding (Weighted Average) (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 11 years of Shares Outstanding (Weighted Average) data on file, last reported at $2.8 million in Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $2.8 million, up 1.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 million (up 1.84% YoY), and the FY2025 annual result was $2.8 million, changed 0.0% from the prior year.
  • Shares Outstanding (Weighted Average) advanced to $2.8 million in Q1 2026 per SLGL's latest filing, from $2.8 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $27.9 million in Q1 2024 and troughed at $2.3 million in Q4 2022.
  • A 5-year average of $13.6 million and a median of $2.8 million in 2026 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Weighted Average) rose 19.59% in 2023, then tumbled 90.0% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $2.3 million in 2022, then rose by 17.11% to $2.7 million in 2023, then increased by 2.85% to $2.8 million in 2024, then gained by 0.0% to $2.8 million in 2025, then grew by 1.83% to $2.8 million in 2026.
  • Business Quant data shows SLGL's Shares Outstanding (Weighted Average) at $2.8 million in Q1 2026, $2.8 million in Q4 2025, and $2.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Sol-Gel Technologies 207.80 Mn 197.67 Mn - 2.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.84 Mn
Dec 31, 2025 2.79 Mn
Sep 30, 2025 2.79 Mn
Mar 31, 2025 2.79 Mn
Dec 31, 2024 2.79 Mn
Sep 30, 2024 2.79 Mn
Jun 30, 2024 27.86 Mn
Mar 31, 2024 27.86 Mn
Dec 31, 2023 2.71 Mn
Sep 30, 2023 27.84 Mn
Jun 30, 2023 27.66 Mn
Mar 31, 2023 24.94 Mn
Dec 31, 2022 2.31 Mn
Jun 30, 2022 23.13 Mn
Mar 31, 2022 23.13 Mn
Dec 31, 2021 23.06 Mn
Jun 30, 2021 23.03 Mn
Mar 31, 2021 23.00 Mn
Dec 31, 2020 22.57 Mn
Sep 30, 2020 23.00 Mn